T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.71% |
| 2 | Healthcare | 16.11% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Sabre
SABR
$892M
| $1.9M | ﹤0.01% |
152,486
-5,376
| -3% | -$75.6K |
|
1752
WaFd
WAFD
$2.79B
| $1.9M | ﹤0.01% |
59,890
-12,306
| -17% | -$401K |
|
1753
UMB Financial
UMBF
$11.4B
| $1.9M | ﹤0.01% |
20,363
-1,088
| -5% | -$103K |
|
1754
Erie Indemnity
ERIE
$13.5B
| $1.89M | ﹤0.01% |
9,766
-7,058
| -42% | -$1.46M |
|
1755
SITE Centers
SITC
$156M
| $1.88M | ﹤0.01% |
160,287
-46,443
| -22% | -$532K |
|
1756
Cardlytics
CDLX
$24.7M
| $1.88M | ﹤0.01% |
1,482
-43
| -3% | -$48.5K |
|
1757
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $1.87M | ﹤0.01% |
6,013
-1,984
| -25% | -$597K |
|
1758
Prestige Consumer Healthcare
PBH
$2.43B
| $1.87M | ﹤0.01% |
35,923
-5,122
| -12% | -$246K |
|
|
FLNA
1759
Filana Therapeutics
FLNA
$45.7M
| $1.87M | ﹤0.01% |
21,909
-13,797
| -39% | -$739K |
|
1760
Simmons First National
SFNC
$3.45B
| $1.87M | ﹤0.01% |
63,727
-953
| -1% | -$28.5K |
|
1761
United Bankshares
UBSI
$6.66B
| $1.86M | ﹤0.01% |
51,092
-3,681
| -7% | -$145K |
|
1762
Watts Water Technologies
WTS
$12.9B
| $1.86M | ﹤0.01% |
12,784
+2,580
| +25% | +$341K |
|
1763
Crane NXT
CXT
$2.96B
| $1.86M | ﹤0.01% |
58,009
+2,827
| +5% | +$92.3K |
|
|
GRTS
1764
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $1.86M | ﹤0.01% |
203,870
-107,625
| -35% | -$995K |
|
1765
Granite Construction
GVA
$5.41B
| $1.86M | ﹤0.01% |
44,681
-6,078
| -12% | -$241K |
|
|
TMHC
1766
DELISTED
Taylor Morrison
TMHC
| $1.85M | ﹤0.01% |
70,183
-1,908
| -3% | -$56.7K |
|
|
PACW
1767
DELISTED
PacWest Bancorp
PACW
| $1.84M | ﹤0.01% |
44,829
+693
| +2% | +$29.6K |
|
1768
iShares Russell 1000 Value ETF
IWD
$84.3B
| $1.83M | ﹤0.01% |
11,551
-537,179
| -98% | -$85M |
|
|
MNDT
1769
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1.83M | ﹤0.01% |
90,611
-5,053
| -5% | -$104K |
|
1770
MillerKnoll
MLKN
$1.64B
| $1.83M | ﹤0.01% |
38,785
-3,241
| -8% | -$147K |
|
1771
National Health Investors
NHI
$3.47B
| $1.82M | ﹤0.01% |
27,214
+1,524
| +6% | +$106K |
|
1772
Saic
SAIC
$5.35B
| $1.82M | ﹤0.01% |
20,806
-245,504
| -92% | -$21.9M |
|
1773
EnerSys
ENS
$6.81B
| $1.82M | ﹤0.01% |
18,659
-1,023
| -5% | -$95.4K |
|
1774
Werner Enterprises
WERN
$2.31B
| $1.82M | ﹤0.01% |
40,908
-637
| -2% | -$29.7K |
|
1775
Viasat
VSAT
$11.4B
| $1.81M | ﹤0.01% |
36,424
-17,178
| -32% | -$854K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.